Search Results - "Mahfoud, Felix"

Why healthcare providers' adherence to guideline‐directed medical therapy is only half the battle.

Authors: Schulz, Martin Mahfoud, Felix Laufs, Ulrich

Source: European Journal of Heart Failure. Dec2025, Vol. 27 Issue 12, p2732-2734. 3p.

The Synergistic Treatment of Heart and Kidney Disease.

Authors: Mahfoud, Felix Götzinger, Felix Kramann, Rafael et al.

Source: Deutsches Ärzteblatt International. 1/9/2026, Vol. 123 Issue 1, p1-1. 1p.

Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease.

Authors: Schlaich, Markus P. Mahfoud, Felix Böhm, Michael et al.

Source: Hypertension (0194911X). Dec2025, Vol. 82 Issue 12, p2252-2261.

Debate on the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: New Blood Pressure Targets, Lower Is Better—And Possible.

Authors: Lauder, Lucas Rahimi, Kazem Böhm, Michael et al.

Source: Hypertension (0194911X). Oct2025, Vol. 82 Issue 10, p1551-1558.

Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.

Authors: Xiongjing Jiang Mahfoud, Felix Wei Li et al.

Source: Circulation. 11/12/2024, Vol. 150 Issue 20, p1588-1598. 11p.

Renal denervation for the treatment of ventricular arrhythmias: A systematic review and meta‐analysis.

Authors: Prado, Gabriela M. Mahfoud, Felix Lopes, Renato D. et al.

Source: Journal of Cardiovascular Electrophysiology. May2021, Vol. 32 Issue 5, p1430-1439. 10p. 1 Diagram, 2 Charts, 2 Graphs.

Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic Variants.

Authors: Delles, Christian Schmieder, Roland E. Daly, Rónán et al.

Source: Hypertension (0194911X). Jan2025, Vol. 82 Issue 1, p118-125.

Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure.

Authors: Guimarães, Pedro Keller, Andreas Böhm, Michael et al.

Source: Hypertension (0194911X). Jan2025, Vol. 82 Issue 1, p46-56.

The current position of β-blockers in hypertension: guidelines and clinical practice.

Authors: Mahfoud, Felix Wang, Jiguang Ray, Saumitra

Source: Current Medical Research & Opinion. 2024 Suppl 1, Vol. 40, p25-32. 8p.

Management of Resistant Hypertension.

Authors: Lauder, Lucas Mahfoud, Felix Böhm, Michael

Source: Annual Review of Medicine. 2024, Vol. 75 Issue 1, p443-457. 16p.

Inducibility of atrial fibrillation after catheter ablation predicts recurrences of atrial fibrillation: a meta‐analysis.

Authors: Millenaar, Dominic Becker, Nicolas Pavlicek, Valérie et al.

Source: Pacing & Clinical Electrophysiology. Apr2021, Vol. 44 Issue 4, p667-676.

Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension.

Authors: Gottlieb, Lisa A. Mahfoud, Felix Stavrakis, Stavros et al.

Source: Hypertension (0194911X). Oct2024, Vol. 81 Issue 10, p2027-2037.

Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality.

Authors: Lauder, Lucas Schwantke, Igor de la Sierra, Alejandro et al.

Source: Hypertension (0194911X). Jun2026, Vol. 83 Issue 6, pe26112-e26112.

Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and Mortality.

Authors: Böhm, Michael de la Sierra, Alejandro Schwantke, Igor et al.

Source: Hypertension (0194911X). Jun2026, Vol. 83 Issue 6, pe26084-e26084.

Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension.

Authors: Lauder, Lucas Siwy, Justyna Mavrogeorgis, Emmanouil et al.

Source: Hypertension (0194911X). Jun2024, Vol. 81 Issue 6, p1374-1382.

Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.

Authors: Townsend, Raymond R. Ferdinand, Keith C. Kandzari, David E. et al.

Source: Hypertension (0194911X). May2024, Vol. 81 Issue 5, p1095-1105.

Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.

Authors: Mahfoud, Felix Mancia, Giuseppe Schmieder, Roland E. et al.

Source: Journal of the American College of Cardiology (JACC). Nov2022, Vol. 80 Issue 20, p1871-1880. 10p.

Renal Denervation Lowers Nighttime Blood Pressure in True Resistant Hypertension.

Authors: Kario, Kazuomi Kandzari, David E. Mahfoud, Felix et al.

Source: Hypertension (0194911X). Dec2024, Vol. 81 Issue 12, pe200-e202.

Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome.

Authors: Tokcan, Mert Hohl, Mathias Schneider, Carolin Victoria et al.

Source: Hypertension (0194911X). Apr2026, Vol. 83 Issue 4, pe26601-e26601.

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.

Authors: Mahfoud, Felix Kandzari, David E Kario, Kazuomi et al.

Source: Lancet. 4/9/2022, Vol. 399 Issue 10333, p1401-1410. 10p.